Table 1.

Baseline characteristics of simulation cohort

	Mean (SD)			References
	rt-CGM (n = 344)	SMBG (n = 35,736)	Combined cohort (n = 36,080)
Patient demographics
Age, years	59.1 (14.5)	64.6 (12.1)	64.5 (12.2)	[12]
Male, %	52.9	50.4	50.5	[12]
Duration of diabetes, years	17.1 (11.1)	15.8 (8.8)	15.8 (8.8)	[12]
Risk factors
HbA1c, %	8.20 (1.5)	8.27 (1.6)	8.27 (1.6)	[12]
HbA1c, mmol/mol	70	70	70	[12]
BMI, kg/m2	30.0 (6.6)	33.4 (7.5)	33.4 (7.5)	[12]
eGFR, mL/min/1.73 m2			72.8 (26.6)	[12]
Systolic blood pressure, mmHg			130.7 (15.7)	[12]
Diastolic blood pressure, mmHg			69.5 (11.2)	[12]
Total cholesterol, mg/dL			156.5 (43.1)	[12]
High-density lipoprotein cholesterol, mg/dL			44.6 (12.2)	[12]
Low-density lipoprotein cholesterol, mg/dL			81.4 (33.3)	[12]
Triglycerides, mg/dL			170.6 (136.7)	[12]
Heart rate, beats/min			72 (12)	[19]
Smoking status, %			5.9	[12]
Racial/ethnic group
White European, %			55.7	[12]
African American, %			10.5	[12]
Hispanic, %			14.3	[12]
Asian/Pacific Islander, %			19.5	[12]
Cardiovascular disease
Angina pectoris, %			11.6	[12]
Myocardial infarction, %			5.1	[12]
Congestive heart failure, %			14,1	[12]
Stroke, %			3.7	[12]
Peripheral vascular disease, %			14.6	[12]
Renal disease
Microalbuminuria, %			54.7	[12]
Gross proteinuria, %			10.1	[12]
ESRD, %			2.2	[12]
Retinopathy
Background diabetic retinopathy, %			31.3	[20]
Proliferative diabetic retinopathy, %			9.2	[12]
Foot ulcer
Peripheral neuropathy, %			44.7	[12]
Healed ulcer, %			10	[12]
Amputation, %			3.3	[12]
Other eye complications
Macular edema, %			9.0	[21]
Cataract, %			11.0	[21]

BMI body mass index, ESRD end-stage renal disease, HbA1c glycated hemoglobin, rt-CGM real-time continuous glucose monitoring, SD standard deviation, SMBG self-monitoring of blood glucose